Design of Experiments for Pharmaceutical Product Development : Volume II : Applications and Practical Case Studies
Intro -- Contents -- About the Editor -- 1: Introduction to the Application of Experimental Designs in Pharmaceutical Product Development -- 1.1 Introduction -- 1.2 Early History and Evolution of Experimental Designs -- 1.3 Experimental Design Principles -- 1.3.1 Replication -- 1.3.2 Randomization -- 1.3.3 Blocking or Error Control -- 1.4 General Considerations in Performing DoE -- 1.4.1 Defining the Problem -- 1.4.2 Establishment of Cause-and-Effect Relationship -- 1.4.3 Selection of Critical Factors by Screening -- 1.4.4 Selection of the Critical Response Variable(s) -- 1.4.5 Experimental Design-Based Factor Optimization -- 1.4.6 Selection of Optimum Solution and Model Validation -- 1.5 Experimental Design Selection and Types -- 1.5.1 Screening Designs -- 1.5.1.1 Fractional Factorial Design -- 1.5.1.2 Taguchi Design -- 1.5.1.3 Plackett-Burman Design -- 1.5.2 Response Surface Designs -- 1.5.2.1 Full Factorial Design -- 1.5.2.2 Central Composite Design -- 1.5.2.3 Box-Behnken Design -- 1.5.2.4 Optimal Designs -- 1.5.2.5 Mixture Designs -- 1.6 Applications of DoE in Drug Product Development -- 1.6.1 Oral Drug Delivery Systems -- 1.6.2 Non-oral Drug Delivery Systems -- 1.7 Conclusion and Future Perspectives -- References -- 2: Design of Experiments for the Development of Solid Oral Dosage Forms -- 2.1 Introduction -- 2.2 DoE Application for Developing the Solid Dosage Forms -- 2.2.1 In the Development of Tablet Dosage Forms -- 2.2.2 In the Development of Capsule Dosage Form -- 2.2.3 In the Tablet Coating Process -- 2.2.4 In the Pharmaceutical Pellets Manufacturing -- 2.3 Conclusion and Future Directions -- References -- 3: Design of Experiments for the Development of Topical Drug Products -- 3.1 Introduction -- 3.2 Advantages of Topical Drug Delivery -- 3.3 Challenges in Topical Delivery -- 3.4 Role of Nanocarriers in Topical Delivery..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
2021 ©2021 |
---|---|
Erschienen: |
Singapore: Springer Singapore Pte. Limited ; 2021 ©2021 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Beg, Sarwar [HerausgeberIn] |
---|
Links: |
ebookcentral.proquest.com [lizenzpflichtig] |
---|
ISBN: |
---|
BKL: | |
---|---|
Themen: |
Anmerkungen: |
Description based on publisher supplied metadata and other sources |
---|
Umfang: |
1 Online-Ressource (190 Seiten) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
178888504X |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 178888504X | ||
003 | DE-627 | ||
005 | 20230905070655.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220208s2021 xx |||||o 00| ||eng c | ||
020 | |a 9789813343511 |9 978-981-334-351-1 | ||
035 | |a (DE-627)178888504X | ||
035 | |a (DE-599)KEP061183229 | ||
035 | |a (EBC)EBC6462431 | ||
035 | |a (EBL)EBL6462431 | ||
035 | |a (EBP)061183229 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
082 | 0 | |a 615.19 | |
084 | |a 44.40 |2 bkl | ||
245 | 1 | 0 | |a Design of Experiments for Pharmaceutical Product Development |b Volume II : Applications and Practical Case Studies |
264 | 1 | |a Singapore |b Springer Singapore Pte. Limited |c 2021 | |
264 | 4 | |c ©2021 | |
300 | |a 1 Online-Ressource (190 Seiten) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Description based on publisher supplied metadata and other sources | ||
520 | |a Intro -- Contents -- About the Editor -- 1: Introduction to the Application of Experimental Designs in Pharmaceutical Product Development -- 1.1 Introduction -- 1.2 Early History and Evolution of Experimental Designs -- 1.3 Experimental Design Principles -- 1.3.1 Replication -- 1.3.2 Randomization -- 1.3.3 Blocking or Error Control -- 1.4 General Considerations in Performing DoE -- 1.4.1 Defining the Problem -- 1.4.2 Establishment of Cause-and-Effect Relationship -- 1.4.3 Selection of Critical Factors by Screening -- 1.4.4 Selection of the Critical Response Variable(s) -- 1.4.5 Experimental Design-Based Factor Optimization -- 1.4.6 Selection of Optimum Solution and Model Validation -- 1.5 Experimental Design Selection and Types -- 1.5.1 Screening Designs -- 1.5.1.1 Fractional Factorial Design -- 1.5.1.2 Taguchi Design -- 1.5.1.3 Plackett-Burman Design -- 1.5.2 Response Surface Designs -- 1.5.2.1 Full Factorial Design -- 1.5.2.2 Central Composite Design -- 1.5.2.3 Box-Behnken Design -- 1.5.2.4 Optimal Designs -- 1.5.2.5 Mixture Designs -- 1.6 Applications of DoE in Drug Product Development -- 1.6.1 Oral Drug Delivery Systems -- 1.6.2 Non-oral Drug Delivery Systems -- 1.7 Conclusion and Future Perspectives -- References -- 2: Design of Experiments for the Development of Solid Oral Dosage Forms -- 2.1 Introduction -- 2.2 DoE Application for Developing the Solid Dosage Forms -- 2.2.1 In the Development of Tablet Dosage Forms -- 2.2.2 In the Development of Capsule Dosage Form -- 2.2.3 In the Tablet Coating Process -- 2.2.4 In the Pharmaceutical Pellets Manufacturing -- 2.3 Conclusion and Future Directions -- References -- 3: Design of Experiments for the Development of Topical Drug Products -- 3.1 Introduction -- 3.2 Advantages of Topical Drug Delivery -- 3.3 Challenges in Topical Delivery -- 3.4 Role of Nanocarriers in Topical Delivery. | ||
650 | 0 | |a Drug development | |
650 | 4 | |a Electronic books | |
689 | 0 | 0 | |D s |0 (DE-588)4143176-5 |0 (DE-627)104408812 |0 (DE-576)209724234 |a Arzneimittelentwicklung |2 gnd |
689 | 0 | |5 (DE-627) | |
700 | 1 | |a Beg, Sarwar |e herausgeberin |4 edt | |
776 | 1 | |z 9789813343504 | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9789813343504 |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/kxp/detail.action?docID=6462431 |m X:EBC |x Aggregator |z lizenzpflichtig |
912 | |a ZDB-30-PQE | ||
912 | |a GBV_ILN_20 | ||
912 | |a ISIL_DE-84 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OPC-PHA | ||
912 | |a SSG-OPC-DE-84 | ||
912 | |a GBV_ILN_24 | ||
912 | |a ISIL_DE-8 | ||
912 | |a GBV_ILN_206 | ||
912 | |a ISIL_DE-Brg3 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a ISIL_DE-289 | ||
936 | b | k | |a 44.40 |j Pharmazie |j Pharmazeutika |0 (DE-627)106423304 |
951 | |a BO | ||
953 | |2 045F |a 615.19 | ||
980 | |2 20 |1 01 |x 0084 |b 4053375266 |h CATDESC_EBC-EB |u CATDESC_EBC-EB |y z |z 09-02-22 | ||
980 | |2 24 |1 01 |x 0008 |b 4158346770 |h olr-ddaebc |k Diesen Titel können Sie über den Zugriffslink zunächst für kurze Zeit nutzen (1 Campuszugriff zur Zeit möglich) und bei weiterem Bedarf nach persönlicher Registrierung auf der nachfolgenden Seite der Zentralbibliothek zur dauerhaften Anschaffung vorschlagen. Wir werden Sie zügig über die Bereitstellung informieren. |y z |z 29-06-22 | ||
980 | |2 206 |1 01 |x 3350 |b 4158223032 |c 00 |f --%%-- |d Online-Ressource |e g |j --%%-- |h OLR-EBL |k If you are a ThHF affiliate and the E-Book is not fully accessible, please send us a purchase or short time loan request. All others: Inter-library loans and guest access on campus premises is not possible. |y zh |z 29-06-22 | ||
980 | |2 2021 |1 01 |x DE-289 |b 4156269760 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l01 |z 24-06-22 | ||
981 | |2 20 |1 01 |x 0084 |r https://ebookcentral.proquest.com/lib/tubraunschweig-ebooks/detail.action?docID=6462431 | ||
981 | |2 24 |1 01 |x 0008 |r https://ebookcentral.proquest.com/lib/christianalbrechts/detail.action?docID=6462431 | ||
981 | |2 206 |1 01 |x 3350 |y Full Text only for ThHf affiliates |r https://thh-friedensau.idm.oclc.org/login?url=http://ebookcentral.proquest.com/lib/thhfriedensau/detail.action?docID=6462431 | ||
981 | |2 2021 |1 01 |x DE-289 |r https://ebookcentral.proquest.com/lib/kiz-uniulm/detail.action?docID=6462431 | ||
995 | |2 20 |1 01 |x 0084 |a CATDESC_EBC-EB | ||
995 | |2 20 |1 01 |x 0084 |a ACQ | ||
995 | |2 24 |1 01 |x 0008 |a olr-ddaebc | ||
995 | |2 206 |1 01 |x 3350 |a OLR-EBL |